Jinhai Medical Technology (HKSE:02225) Shares Outstanding (EOP): 5,290.0 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:02225 Jinhai Medical Technology Ltd HKSE:02225
61 GF Score
Price HK$6.11
GF Value HK$1.41
Valuation Significantly Overvalued
! 9 Warning Signs
View Full Analysis

What is Jinhai Medical Technology Shares Outstanding (EOP)?

Jinhai Medical Technology HKSE:02225 -6.14% 61 Shares Outstanding (EOP) is 5,290.0 Mil as of Dec. 2025. GuruFocus rates HKSE:02225 with a GF Score™ of 61/100 and a GF Value™ of HK$1.41 (Significantly Overvalued). The stock has 9 warning signs investors should review.

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. Jinhai Medical Technology's shares outstanding for the quarter that ended in Dec. 2025 was 5,290.0 Mil.

Jinhai Medical Technology's quarterly shares outstanding increased from Jun. 2025 (5,170.0 Mil) to Dec. 2025 (5,290.0 Mil). It means Jinhai Medical Technology issued new shares from Jun. 2025 to Dec. 2025 .

Jinhai Medical Technology's annual shares outstanding increased from Dec. 2024 (5,170.0 Mil) to Dec. 2025 (5,290.0 Mil). It means Jinhai Medical Technology issued new shares from Dec. 2024 to Dec. 2025 .


Jinhai Medical Technology  (HKSE:02225) Shares Outstanding (EOP) Explanation

A company may buy back shares or issue shares in any fiscal period. If a company buys back shares, we should observe that the total number of shares decline. If the company issues new shares, the number of shares outstanding increases.

Usually the presence of treasury shares and a history of buyback are good indicators that company has competitive advantage. But studies have shown that companies usually buy back at wrong time. Buying back shares below its intrinsic value increases value for remaining shareholders. Buying back overvalued shares destroys value for existing shareholders.


Be Aware

Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred net income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.

Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.

If net earnings is less than 10%, likely to be in a highly competitive business.


Jinhai Medical Technology Shares Outstanding (EOP) Related Terms


Jinhai Medical Technology Shares Outstanding (EOP) Historical Data

* Premium members only.

The historical data trend for Jinhai Medical Technology's Shares Outstanding (EOP) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Jinhai Medical Technology Shares Outstanding (EOP) Chart

Jinhai Medical Technology Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Shares Outstanding (EOP)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4,920.00 4,920.00 5,170.00 5,170.00 5,290.00

Jinhai Medical Technology Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Shares Outstanding (EOP) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5,170.00 5,170.00 5,170.00 5,290.00 5,290.00

HKSE:02225 vs RHI, KFY, TNET: Shares Outstanding (EOP) Comparison

For the Conglomerates subindustry, Jinhai Medical Technology's Shares Outstanding (EOP), along with its competitors' market caps and Shares Outstanding (EOP) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Jinhai Medical Technology Shares Outstanding (EOP) vs Conglomerates Industry

For the Conglomerates industry and Industrials sector, Jinhai Medical Technology's Shares Outstanding (EOP) distribution charts can be found below:

* The bar in red indicates where Jinhai Medical Technology's Shares Outstanding (EOP) falls into.


HKSE:02225
61GF Score
Jinhai Medical Technology Ltd HKSE:02225
Shares Outstanding (EOP) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Jinhai Medical Technology Shares Outstanding (EOP) Calculation

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. They have voting rights and represent ownership in the corporation by the person that holds the shares. They should be distinguished from treasury shares, which are shares held by the corporation itself, having no exercisable rights.

Shares outstanding can be calculated as either basic or fully diluted. The fully diluted shares outstanding count includes diluting securities, such as options, warrants or convertibles.

Please note: GuruFocus named Shares Outstanding (EOP) is the shares for that end of period. It is usually used to calculate balance sheet related items, such as Book Value per Share, etc. While Shares Outstanding (Diluted Average) and Shares Outstanding (Basic Average) are the weighted average shares over a period of time (a year, a quarter, or so). They are usually used to calculate income statement or cashflow statement related items, such as Earnings per Share (Diluted), etc.

What does a Shares Outstanding (EOP) of 5,290.0 Mil mean?
Jinhai Medical Technology (HKSE:02225) has a Shares Outstanding (EOP) of 5,290.0 Mil as of Dec. 2025. The total shares a company has outstanding, at period-end. View historical data on Jinhai Medical Technology and its competitors.
Is Jinhai Medical Technology's Shares Outstanding (EOP) too high?
Jinhai Medical Technology's current Shares Outstanding (EOP) is 5,290.0 Mil. Overall, Jinhai Medical Technology has a GF Score™ of 61/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Jinhai Medical Technology's Shares Outstanding (EOP) compare to RHI and KFY?
Jinhai Medical Technology's Shares Outstanding (EOP) of 5,290.0 Mil can be compared against companies in the Conglomerates industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shares Outstanding (EOP) for a Conglomerates company?
A good Shares Outstanding (EOP) depends on the Conglomerates industry context. However, Shares Outstanding (EOP) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shares Outstanding (EOP) mean?
A high Shares Outstanding (EOP) can signal that a stock is expensive relative to its fundamentals. The total shares a company has outstanding, at period-end. View historical data on Jinhai Medical Technology and its competitors. Jinhai Medical Technology's current Shares Outstanding (EOP) is 5,290.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jinhai Medical Technology stock overvalued right now?
Based on GuruFocus' analysis, Jinhai Medical Technology (HKSE:02225) is currently considered Significantly Overvalued. The stock's GF Value™ is HK$1.41, compared to a current price of HK$6.11 — trading 333.3% above its estimated fair value. The current Shares Outstanding (EOP) is 5,290.0 Mil. Jinhai Medical Technology's overall GF Score™ is 61/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shares Outstanding (EOP) calculated?
Shares Outstanding (EOP) is calculated from a company's financial statements. For Jinhai Medical Technology (HKSE:02225), the current Shares Outstanding (EOP) is 5,290.0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Jinhai Medical Technology (HKSE:02225) Overvalued in 2026?

Based on GuruFocus' analysis, Jinhai Medical Technology stock appears to be overvalued. The current stock price of HK$6.11 is trading 333.3% above its estimated GF Value™ of HK$1.41. GuruFocus considers Jinhai Medical Technology to be Significantly Overvalued.

Key valuation signals for HKSE:02225:

  • Shares Outstanding (EOP): 5,290.0 Mil
  • GF Value™: HK$1.41 vs. price of HK$6.11 (333.3% above fair value)
  • GF Score™: 61/100 with 9 warning signs

No single metric tells the full story. See the HKSE:02225 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Jinhai Medical Technology Business Description

Address 1275 Meichuan Road, 3rd Floor, Block East, Putuo District, Shanghai, CHN
Jinhai Medical Technology Ltd is an investment holding company. Along with its subsidiaries, it is principally engaged in providing medical equipment in China and manpower outsourcing and ancillary services to building and construction contractors in Singapore. The group also provides IT services, construction ancillary services (which comprise warehousing, cleaning, and building maintenance works), and dormitory services in Singapore. It generates maximum revenue from the sale of minimally invasive surgery solutions, medical products, and related services in the People's Republic of China.
61GF Score

Get the complete analysis for HKSE:02225

Shares Outstanding (EOP) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$6.11
Price
HK$1.41
GF Value